K
Kazia Therapeutics Limited D
D
KZIA
11.910
USD
-0.31
(-2.54%)
مغلق
حجم التداول
11,882
الربح لكل سهم
-5
العائد الربحي
-
P/E
-2
حجم السوق
136,094,367
المقالات
العنوان: Kazia Therapeutics Limited
القطاع: Healthcare
الصناعة: Biotechnology
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.